“This Patient Needs a Doctor - Not a Guideline!” The Zone of Uncertainty in PAWP Measurement | AJRCCM

What says you? Jean-Luc Vachiery 🫀 Sandeep Sahay, MD, MSc Montani David Jason Weatherald MD Rebecca Vanderpool, PhD Dr Mardi Gomberg Marco Guazzi MarcSimonMD Greg Lewis Yogesh Reddy

atsjournals.org/doi/metrics/10…

The brilliant Nosheen Reza, MD gave a fantastic talk discussing which device for which shock patient. Loved this slide showing variation in mortality with different MCS in unique CS phenotypes 🤯 #scrippsHF_EP2024 Rola Khedraki, MD, FACC Rajeev Mohan

Never fear, Superman is here

Ladies and gentlemen... 1️⃣8️⃣

Congratulations to ⭐️Angela Duvalyan for leading this effort! Practical advice on addressing MGI/UTI risk with SGLT2i. UTSW Internal Medicine Chiefs UT Southwestern Medical Center UTSW Cardiology Fellowship UTSW Heart Ricardo M. La Hoz #GDMT HFSA UCLA Cardiology Fellowship

Effects of #GDMT across Kidney Function Spectrum

✅ #BB : consistent benefit to eGFR 30
✅ #ARNI : consistent benefit to eGFR 30
✅ #SGLT2i : consistent benefit to eGFR 20
❌ #SteroidalMRA : ↓ benefit & worse safety at lower eGFR

New strategies to block MR axis in HF & CKD needed!

.JACC Journals reference pocket cards for contemporary global guideline recommendations for drugs & devices in HF across the LVEF spectrum.🗒️

jacc.org/doi/10.1016/j.…

#BetaBlocker use in #HFpEF and #HFmrEF ❓

In this month’s issue of #JACCHF , analysis of #DELIVER trial shows:

♥️ 4 out of 5 px were treated with #BB
♥️ #BB use wasn't linked to #worseningHF or #CVdeath
♥️Benefits of #Dapagliflozin remained consistent regardless of #BB
➡️➡️

Latest from us.

At face value this paper is for a narrow audience. However, there may be lessons for those interested in cardiac output measurements over changing conditions.

What a pleasure to contribute to this working group and statement! European Society of Cardiology Journals

🫀In this #CardiogenicShock study, over 1/2 of CS pts at large hubs had been transferred from other hospitals.
They had higher mortality compared to those presenting directly to the hub & this was primarily driven by pts with HF-CS rather than AMI-CS.
🔗bit.ly/43RvGgq

Hot off the press 🔥🔥🔥– AHA Scientific Statement on the Diagnosis and Management of Sarcoidosis. Thank you to AHA Science and the AHA HF and Nursing Councils for the chance to work on this! Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA Michelle Kittleson MD PhD Kristen Patton UWashington Heart Institute - ahajournals.org/doi/epdf/10.11…

This provides a comprehensive overview of diagnosis, treatment options & outcomes of CS, including challenges in diagnosing & the importance of a multidisciplinary approach.

✍🏽 Richard Cheng Michelle Kittleson MD PhD Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP,CACP Ron Blankstein Paco E. Bravo, MD Nisha Gilotra @rhythmkri

On the heals of the WSPH Association, MUSC Cardiology AHFTC fellows Elie Kozaily MD & Ecem Akdogan present our thoughts on management in PH-HFpEF. We hope you enjoy the read! Jennifer Hajj, RN Vishal Rao Anthony Carnicelli, MD FACC Chakradhari Inampudi MUSC-CardiologyFellowshipPrograms

link.springer.com/article/10.100…